1. Home
  2. HUBC vs IMNN Comparison

HUBC vs IMNN Comparison

Compare HUBC & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • IMNN
  • Stock Information
  • Founded
  • HUBC 2017
  • IMNN 1982
  • Country
  • HUBC Israel
  • IMNN United States
  • Employees
  • HUBC N/A
  • IMNN N/A
  • Industry
  • HUBC
  • IMNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBC
  • IMNN Health Care
  • Exchange
  • HUBC Nasdaq
  • IMNN Nasdaq
  • Market Cap
  • HUBC 19.3M
  • IMNN 12.1M
  • IPO Year
  • HUBC N/A
  • IMNN 1985
  • Fundamental
  • Price
  • HUBC $2.42
  • IMNN $0.60
  • Analyst Decision
  • HUBC
  • IMNN Buy
  • Analyst Count
  • HUBC 0
  • IMNN 2
  • Target Price
  • HUBC N/A
  • IMNN $14.00
  • AVG Volume (30 Days)
  • HUBC 1.7M
  • IMNN 1.3M
  • Earning Date
  • HUBC 05-01-2025
  • IMNN 08-13-2025
  • Dividend Yield
  • HUBC N/A
  • IMNN N/A
  • EPS Growth
  • HUBC N/A
  • IMNN N/A
  • EPS
  • HUBC N/A
  • IMNN N/A
  • Revenue
  • HUBC $29,562,000.00
  • IMNN N/A
  • Revenue This Year
  • HUBC N/A
  • IMNN N/A
  • Revenue Next Year
  • HUBC N/A
  • IMNN N/A
  • P/E Ratio
  • HUBC N/A
  • IMNN N/A
  • Revenue Growth
  • HUBC N/A
  • IMNN N/A
  • 52 Week Low
  • HUBC $1.72
  • IMNN $0.37
  • 52 Week High
  • HUBC $14.00
  • IMNN $3.65
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 48.64
  • IMNN 35.40
  • Support Level
  • HUBC $1.78
  • IMNN $0.70
  • Resistance Level
  • HUBC $2.18
  • IMNN $0.86
  • Average True Range (ATR)
  • HUBC 0.19
  • IMNN 0.07
  • MACD
  • HUBC 0.03
  • IMNN -0.03
  • Stochastic Oscillator
  • HUBC 54.29
  • IMNN 0.05

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: